Speaking at the AstraZeneca sponsored satellite symposium 'The revolution in peronalised healthcare: Towards improved outcomes in oncology', at the 2013 European Cancer Congress, Dr Shepherd gives an introduction to the symposium and overview of personalised treatment of non-small cell lung cancer.